fr
en

1 2 3 … 5 Next »

Year: 2021

BRINGING YOU
THE LATEST

December 8, 2021

MedinCell publishes its financial results and activity report for the first half of 2021-2022 (April – September 2021)

Read press release

December 3, 2021

Videoconference and publication of the 2021-2022 Half-Year Results, on December 8, 2021

Read press release

December 1, 2021

MedinCell receives €4 million in funding from Bpifrance and within the framework of the French Recovery Plan (Plan France Relance)

Read press release

November 1, 2021

Phase 3 data of mdc-IRM, first product based on MedinCell’s technology, shows significant improvements in patients with schizophrenia

Read press release

October 25, 2021

MedinCell announces participation in the Jefferies London Healthcare Conference 2021

Read press release

October 22, 2021

MedinCell: mdc-IRM’s Phase 3 data to be presented for the first time by Teva at Psych Congress 2021 (Oct. 29-Nov. 1, 2021, San Antonio, USA)

Read press release

1 2 3 … 5 >

Session en français

Rendez-vous le lundi 14 novembre à 18h00 (CET) pour une vidéoconférence dédiée aux récentes avancées des produits de notre portfeuille clinique

English session

On Monday 14, November at 6.00 pm (CET) participate in our videoconference dedicated to the latest news regarding our clinical and regulatory products

CONTACT